The World Health Organization (WHO) says the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa.
After an expert meeting this week, WHO said there is now enough information to conclude that the two most advanced Ebola vaccines — one made by GlaxoSmithKline and the other licensed by Merck and NewLink — have “an acceptable safety profile.”
In a press briefing on Friday, Dr. Marie-Paule Kieny, who heads WHO’s Ebola vaccine efforts, said “the cupboard [for Ebola vaccines] is filling up rapidly.”
ADVERTISEMENT
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.